Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 45Lung Neoplasms 29Neoplasms 26Colorectal Neoplasms 20Prostatic Neoplasms 14Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Fatigue 9Anxiety Disorders 8Neoplasm Metastasis 7Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Papillomavirus Infections 6Ovarian Neoplasms 5Multiple Myeloma 5Melanoma 5Head and Neck Neoplasms 5Gastrointestinal Neoplasms 5Depression 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Breast Carcinoma In Situ 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3

Interventions

Nivolumab 143pembrolizumab 129Sunitinib 127Bevacizumab 71Everolimus 70Sorafenib 68cabozantinib 64Ipilimumab 61pazopanib 58Axitinib 57aldesleukin 51Magnetic Resonance Spectroscopy 43Cyclophosphamide 40Interleukin-2 38lenvatinib 36Radiosurgery 36Specimen Handling 33Interferon-alpha 32atezolizumab 29belzutifan 24temsirolimus 23Gemcitabine 23fludarabine phosphate 22Radiotherapy 18Interferon alpha-2 18Biopsy 18fludarabine 17durvalumab 17avelumab 17Paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Renal Cell × Educational Status × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡